04 Feb 21
This year’s World Cancer Day’s theme is ‘I Am and I Will’ focused on you and your commitment to act.
Cancer is the second leading cause of death worldwide, with 9.6 million people dying from cancer every year. What is even more shocking is that one in three cancers can be prevented. Not only can some cancers be prevented, a recent UK study found that for the eight most common cancers, survival is three times higher when diagnosed early.
By increasing awareness and promoting accurate information and knowledge, we can empower all of us to recognise the early warning signs and help conquer our fears and misconceptions about cancer.
Oncology drug development is a demanding, complicated and highly competitive area. tranScrip’s experienced and dedicated oncology team work tirelessly to help drive change and shape the next generation of oncology treatments. Our extensive expertise within the oncology space ranges from targeted treatments, immunotherapies, vaccines, cell-based products to novel cytotoxics.
We understand the science and work closely with our clients to accelerate development of new therapies, including targeted treatments, to help meet patients’ needs faster, allowing them to live healthier and more fulfilling lives. Together, all of our actions matter.
We are tranScrip and we will help drive change.
Cancer Research UK. Survival three times higher when cancer is diagnosed early. https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2015-08-10-survival-three-times-higherwhen-cancer-is-diagnosed-early
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.
